Related Experiment Video

Updated: Aug 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Antithrombotic therapy for prosthetic valves: routine treatment and special considerations

A M Al-Ahmad1, D Hartnett-Daudelin, D N Salem

  • 1Division of Cardiology, Department of Medicine, New England Medical Center, Box 79, Boston, MA 02111, USA.

Current Cardiology Reports
|January 5, 2001
PubMed

Insights

Antithrombotic therapy is crucial for preventing blood clots in patients with prosthetic heart valves. This review examines risks and benefits for mechanical and bioprosthetic valves, including special patient populations.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Pharmacology

Background:

  • Prosthetic heart valve use has risen significantly over the last 30 years.
  • Antithrombotic agents are essential for preventing thromboembolic events in patients with prosthetic heart valves.
  • Understanding the nuances of antithrombotic therapy is vital for patient management.

Purpose of the Study:

  • To analyze the risks associated with thromboembolic events in prosthetic heart valve patients.
  • To evaluate the benefits and risks of antithrombotic therapy for mechanical and bioprosthetic heart valves.
  • To review antithrombotic strategies in specific patient groups, including those with intracranial bleeding, pregnant women, and surgical patients.

Main Methods:

  • Comprehensive literature review of studies on prosthetic heart valves and antithrombotic therapy.
  • Analysis of risk factors for thromboembolic events.
  • Synthesis of data on antithrombotic efficacy and safety in diverse patient populations.

Main Results:

  • Antithrombotic therapy remains the cornerstone for preventing thromboembolic complications.
  • Risk-benefit profiles of antithrombotic agents vary between mechanical and bioprosthetic valves.
  • Special considerations are necessary for managing antithrombotic therapy in high-risk groups.

Conclusions:

  • Antithrombotic therapy requires careful individualized management in patients with prosthetic heart valves.
  • Further research is needed to optimize antithrombotic strategies in complex patient scenarios.
  • This review provides a framework for clinical decision-making regarding antithrombotic use in prosthetic heart valve patients.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...